Cargando…

Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer

BACKGROUND: Non-invasive liquid biopsies could complement current pathological nomograms for risk stratification of prostate cancer patients. Development and testing of potential liquid biopsy markers is time, resource, and cost-intensive. For most protein targets, no antibodies or ELISAs for effici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goetze, Sandra, Schüffler, Peter, Athanasiou, Alcibiade, Koetemann, Anika, Poyet, Cedric, Fankhauser, Christian Daniel, Wild, Peter J., Schiess, Ralph, Wollscheid, Bernd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044739/ https://www.ncbi.nlm.nih.gov/pubmed/35477343 http://dx.doi.org/10.1186/s12014-022-09349-x

Ejemplares similares

Apicobasal Surfaceome Architecture Encodes for Polarized Epithelial Functionality and Depends on Tumor Suppressor PTEN
por: Koetemann, Anika, et al.
Publicado: (2022)

A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology
por: Athanasiou, Alcibiade, et al.
Publicado: (2021)

HATRIC-based identification of receptors for orphan ligands
por: Sobotzki, Nadine, et al.
Publicado: (2018)

Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies
por: Steuber, Thomas, et al.
Publicado: (2018)

Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer
por: Fankhauser, Christian D., et al.
Publicado: (2017)

Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer
por: Macagno, Annalisa, et al.
Publicado: (2020)

Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer
por: Endt, Kathrin, et al.
Publicado: (2017)

Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer
por: Rupp, Niels J., et al.
Publicado: (2016)

Single-cell proteomics defines the cellular heterogeneity of localized prostate cancer
por: De Vargas Roditi, Laura, et al.
Publicado: (2022)

Multi-region proteome analysis quantifies spatial heterogeneity of prostate tissue biomarkers
por: Guo, Tiannan, et al.
Publicado: (2018)

Decoding Functional High-Density Lipoprotein Particle Surfaceome Interactions
por: Frey, Kathrin, et al.
Publicado: (2022)

A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients
por: Zhong, Qing, et al.
Publicado: (2017)

Prognostic value of pretreatment inflammatory markers in localised prostate cancer before radical prostatectomy
por: Grogg, Josias Bastian, et al.
Publicado: (2023)

Effectiveness of Flexible Ureterorenoscopy Versus Extracorporeal Shock Wave Lithotripsy for Renal Calculi of 5–15 mm: Results of a Randomized Controlled Trial
por: Fankhauser, Christian Daniel, et al.
Publicado: (2021)

High‐throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification
por: Zhu, Yi, et al.
Publicado: (2019)

Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity
por: Zhong, Qing, et al.
Publicado: (2016)

Prostate cancer detection rate in men undergoing transperineal template‐guided saturation and targeted prostate biopsy
por: Kaufmann, Basil, et al.
Publicado: (2021)

Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer
por: Klocker, Helmut, et al.
Publicado: (2020)

Biomarkers for prostate cancer detection and risk stratification
por: Farha, Mark W., et al.
Publicado: (2022)

Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death
por: Mortezavi, Ashkan, et al.
Publicado: (2017)

Oncological and functional outcomes after testis-sparing surgery in patients with germ cell tumors: a systematic review of 285 cases
por: Grogg, Josias Bastian, et al.
Publicado: (2022)

Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
por: Eickelschulte, Samaneh, et al.
Publicado: (2022)

Limited Value of Bladder Wash Cytology During Follow-Up of Patients With Non-muscle Invasive Bladder Cancer
por: Bieri, Uwe, et al.
Publicado: (2023)

The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy
por: Song, Wan, et al.
Publicado: (2019)

The German version of the Expanded Prostate Cancer Index Composite (EPIC): translation, validation and minimal important difference estimation
por: Umbehr, Martin H., et al.
Publicado: (2018)

Comparative analysis of mRNA and protein degradation in prostate tissues indicates high stability of proteins
por: Shao, Wenguang, et al.
Publicado: (2019)

Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
por: Veeck, Jürgen, et al.
Publicado: (2009)

Prevalence of hypertension and diabetes after exposure to extracorporeal shock-wave lithotripsy in patients with renal calculi: a retrospective non-randomized data analysis
por: Fankhauser, Christian Daniel, et al.
Publicado: (2018)

Extracorporeal shock wave lithotripsy versus flexible ureterorenoscopy in the treatment of untreated renal calculi
por: Fankhauser, Christian D, et al.
Publicado: (2018)

Correction to: Prevalence of hypertension and diabetes after exposure to extracorporeal shock-wave lithotripsy in patients with renal calculi: a retrospective non-randomized data analysis
por: Fankhauser, Christian Daniel, et al.
Publicado: (2018)

Extracorporeal shock wave lithotripsy versus flexible ureterorenoscopy in the treatment of untreated renal calculi
por: Fankhauser, Christian D, et al.
Publicado: (2018)

CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer
por: Wettstein, Marian S., et al.
Publicado: (2015)

Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification
por: Gennaro, Kyle H., et al.
Publicado: (2018)

Assessment of the Utility of Gene Positioning Biomarkers in the Stratification of Prostate Cancers
por: Meaburn, Karen J., et al.
Publicado: (2019)

Identification of a Gene Expression Signature Common to Distinct Cancer Pathways
por: Fankhauser, Niklaus, et al.
Publicado: (2012)

Automated Gleason grading of prostate cancer tissue microarrays via deep learning
por: Arvaniti, Eirini, et al.
Publicado: (2018)

Author Correction: Automated Gleason grading of prostate cancer tissue microarrays via deep learning
por: Arvaniti, Eirini, et al.
Publicado: (2019)

Author Correction: Automated Gleason grading of prostate cancer tissue microarrays via deep learning
por: Arvaniti, Eirini, et al.
Publicado: (2021)

The Hemolymph Proteome of Fed and Starved Drosophila Larvae
por: Handke, Björn, et al.
Publicado: (2013)

TMARKER: A free software toolkit for histopathological cell counting and staining estimation
por: Schüffler, Peter J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_64di5m3g7buiol3clite133m7g